Financial Data

Showing 8334 articles
Business

Elevance Health's Capital Efficiency Raises Questions Amid Growth Push

While the healthcare giant continues to expand its revenue base, a declining trend in its return on capital employed (ROCE) suggests management's aggressive reinvestment strategy may be coming at the cost of near-term profitability. Analysts are divided on whether this signals long-term vision or inefficient capital allocation.

Business

GSK Charts Steady Course After Strong 2025, Eyes Key Launches in 2026

GSK reported robust full-year 2025 results, with sales exceeding £32 billion and profit growth outpacing revenue. Executives outlined a 2026 strategy focused on maximizing recent drug launches, accelerating late-stage pipeline assets, and leveraging technology, while navigating currency headwinds and a profit shift to the second half.